OSE Immunotherapeutics SA's total assets for Q2 2024 were €140.92M, an increase of 72.06% from the previous quarter. FR:OSE total liabilities were €59.47M for the fiscal quarter, a 0.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.